Akoustis Gross Margin

The Gross Margin of Aktis Oncology Inc (AKTS) is -11.49%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

Akoustis Gross Margin - Historical Value

Date	Value
2024-12-31	-11.49%

Akoustis Gross Margin - Peers Comparison

Ticker	Name	Value
MICT	MICT Inc	16.56%
ELTK	Eltek Ltd	15.42%
FLXT	Flexpoint Sensor Systems Inc	68.28%
IEHC	IEH Corp	25.97%
LFUS	Littelfuse Inc	37.97%
NSSC	NAPCO Security Technologies Inc	55.63%
CPSH	CPS Technologies Corp	16.23%
DGNG	Diguang International Development Co Ltd	7.66%
ACSEF	ACS Motion Control Ltd	47.44%
ZTE.CN	Ztest Electronics Inc	41.55%
LGL	LGL Group Inc	52.96%
ROG	Rogers Corp	31.67%
SIVE.ST	Sivers Semiconductors AB	31.80%
BDC	Belden Inc	37.99%
DYSL	Dynasil Corporation of America	36.78%
YNV.V	Ynvisible Interactive Inc	39.62%
BELFA	Bel Fuse Inc	39.15%
INRD	Inrad Optics Inc	38.15%
KN	Knowles Corp	43.95%
AIRG	Airgain Inc	43.54%
APH	Amphenol Corp	37.22%
NLST	Netlist Inc	1.96%
IIVI	II-VI Inc	38.16%
MPAD	Teledyne Micropac Inc	35.53%
VSH	Vishay Intertechnology Inc	19.38%
CVAT	Cavitation Technologies Inc	81.28%
GLW	Corning Inc	35.97%